MARTHA DEMSKI - 07 Mar 2022 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Martha J. Demski, by Brian Lenz as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
07 Mar 2022
Transactions value $
$0
Form type
4
Filing time
09 Mar 2022, 16:58:46 UTC
Previous filing
24 Nov 2021
Next filing
17 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Award $0 +26,586 +633% $0.000000 30,786 07 Mar 2022 See footnote F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Employee Stock Option (right to buy) Award $0 +53,172 $0.000000 53,172 07 Mar 2022 Common Stock 53,172 $1.67 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.
F2 Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 4,200 shares of common stock owned by the reporting person.
F3 These shares are held in the trust account of the Martha J. Demski Trust U/D/T 10/01/94, for which the reporting person serves as trustee.
F4 The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.